期刊
ORGANIC & BIOMOLECULAR CHEMISTRY
卷 14, 期 13, 页码 3345-3349出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ob00208k
关键词
-
资金
- MIT startup funds
- Sontag Foundation Distinguished Scientist Award
- MIT/NIGMS Biotechnology Training Program [5T32GM008334-25]
- Bayerische Forschungsstiftung
H2 relaxin is a pleiotropic peptide hormone with clinical potential. Here we report on the reaction and use of hexafluorobenzene as an intramolecular disulfide replacement between Cys10 and Cys15 in the A-chain of H2 relaxin. Using flow-based Fmoc solid-phase peptide synthesis methodology we were able to obtain high-quality H2 relaxin fragments that were previously reported as challenging to synthesize. Subsequent native chemical ligation and oxidative folding enabled total synthesis of both wild type H2 relaxin and a C6F4 linked analog. Cell-based activity assays revealed modest activity for the C6F4 linked H2 relaxin analog, albeit 100-fold reduced relative to wild type. This work demonstrates how perfluoroarylation-cysteine SNAr chemistry may be a useful tool for the selective replacement of native disulfide bonds in proteins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据